15 results about "Therapy Preparation" patented technology

1. Name of the design product: Graphic user interface for operating a therapeutic instrument for electronic devices. 2. Use of the design product: For an electronic device. 3. Design key points of the design product: Lies in the graphic user interface. 4. Picture or photo that best shows the design key points: The front view of Design 2. 5. Other views are conventional designs, and other views are omitted. 6. Design 2 is designated as the basic design. 7. Use of the graphic user interface: This interface is used to control parameters such as the start and stop of the therapeutic instrument, treatment levels, treatment time, etc. The front view of Design 1 is the initial interface. The first interface change state diagram of Design 1 is the interface presented after clicking the start button in the middle of the bottom of the front view of Design 1. This interface is the treatment preparation interface. The second interface change state diagram of Design 1 is the interface presented when the therapeutic instrument device detects that the treatment head touches the skin in the first interface change state diagram of Design 1. The interaction of Design 2 and Design 3 is the same as that of Design 1.

Systems, devices, and methods may be deployed to process and / or prepare volumes of suspension therapy for infusion into a patient by, for example, receiving a volume of therapeutic suspension and then processing it to, for example, remove waste, adjust concentration of therapeutic agents suspended in the therapeutic suspension, and / or otherwise prepare the therapeutic suspension for infusion into a patient. The systems, device, and / or methods may use one or more microfluidic devices to process the therapeutic suspension and prepare it for use. When therapeutic agents suspended within the therapeutic suspension are cells, the systems, devices, and / or methods disclosed herein may be deployed as a bioreactor to, for example, feed the cells and / or otherwise maintain viability prior to infusion and / or use.

The invention provides an artificial intelligence guided radiotherapy accurate positioning system, and relates to the technical field of medical treatment, the system comprises a data acquisition and processing module, an anatomical change intelligent analysis module and a positioning guide instruction generation module, and the anatomical change intelligent analysis module comprises a deformation registration unit and an intelligent judgment unit; according to the method, the difference between the current anatomical structure and the original plan is automatically compared before each treatment, and the clinical significance of the change is intelligently judged, so that a differentiated precise guide strategy is realized: when the change is not significant, the system quickly completes high-precision positioning verification, the treatment preparation time is greatly shortened, and the treatment efficiency is improved; when the change is obvious, the system not only can accurately map the target area and calculate the current positioning error, but also can actively send out early warning needing doctor intervention, thereby effectively avoiding the risk of target area leakage irradiation or excessive irradiation of normal tissues caused by the change of the anatomical structure, and providing key decision support for clinical implementation of adaptive radiotherapy.

The invention relates to the technical field of biomedicine and cardiovascular disease treatment, and discloses application of an Aralar myocardial overexpression virus in preparation of a medicine for treating heart failure. The related product is a gene therapy preparation containing an effective amount of AAV9-cTnT-Aralar, and can be matched with pharmaceutically acceptable carriers, diluents and other auxiliary materials, and the preparation is an injection type. The preparation method comprises the following steps: firstly, constructing a cardiac troponin T-carrying promoter and an AAV9 carrier of an Aralar coding nucleic acid to form a recombinant adeno-associated virus, and then matching the virus with proper auxiliary materials to prepare the preparation. The product can be used for treating heart failure accompanied with mitochondrial dysfunction, can realize heart targeted delivery and myocardial cell specific overexpression of Aralr, relieves the heart failure course by improving the myocardial cell mitochondrial function and dynamic balance, and is good in preparation stability, convenient in administration and adaptive to clinical application requirements.

The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine smoking therapy preparation for lung diseases based on thermal driven drug release, which is characterized by comprising the following traditional Chinese medicine raw materials in parts by mass: 15-25 parts of bitter almond, 8-12 parts of bulbus fritillariae cirrhosae, 12-18 parts of platycodon grandiflorum, 10-15 parts of fructus perillae, 10-15 parts of flos farfarae, 12-18 parts of radix stemonae, 20-30 parts of herba houttuyniae and 15-20 parts of radix scutellariae. The thermal adaptation auxiliary material is prepared from 30%-40% of microcrystalline cellulose, 5%-8% of magnesium stearate, 2%-3% of menthol and the balance of lactose. By accurately controlling the formula and the preparation process of the traditional Chinese medicine raw materials, the preparation can realize controllable volatilization and release of the active ingredients of the traditional Chinese medicine under the thermal condition of 300-400 DEG C. Experimental data show that under the condition, the symptom remission rate of a patient can reach 70%-85%, which is obviously superior to that of a traditional treatment method.

The invention relates to the technical field of traditional Chinese medicines, and particularly discloses a navel therapy composition and a navel therapy preparation for preventing and treating abdominal pain caused by intravenous drip of azithromycin in children and a preparation method of the navel therapy composition and the navel therapy preparation. The technical key points are as follows: the fructus evodiae and the dysentery are combined according to a specific weight ratio, and are matched with pharmaceutic adjuvants such as a transdermal enhancer and an excipient to prepare special navel therapy dosage forms such as pills, cakes, patches and the like. According to the composition, by utilizing the characteristics that the Shenque acupoint (navel) epidermal cuticle is thin, the barrier function is weak, blood vessels are rich, and medicines are easy to disperse and absorb, adverse reactions such as gastrointestinal spasmodic pain, nausea and vomiting and the like caused by intravenous drip of azithromycin in children are effectively relieved through an administration mode of external application. Through clinical verification, the umbilical therapy preparation can remarkably reduce the incidence rate and severity score of stomachache, vomiting and diarrhea, and remarkably improve the treatment compliance of child patients.

The present application belongs to the technical field of biological medicine, and relates to a gene therapy preparation for treating drug-resistant renal cell carcinoma as well as a preparation method and application thereof. It is found for the first time that UBL3 is a key gene for mediating cross-resistance of VEGFR inhibitors of renal cancer, and a lipid nanoparticle composite system integrating specific gene editing and active targeted delivery functions is constructed based on this. The preparation can effectively restore the sensitivity of drug-resistant tumors to first-line drugs such as sunitinib, and shows a significant anticancer effect in in-vivo and in-vitro models, and has important clinical transformation value.

The utility model relates to a moxibustion therapy bed special supervisor moxa bag, it includes the luggage of upper middle and lower structure and the accommodation in the at least one moxa bag of the middle box body of luggage and the accommodation in the at least one supervisor moxa auxiliary material of upper box body of luggage. The lower box body inside is provided with electric heating plate, the movable installation of multiple partition plates in the middle box body is in the vertical state, the bottom wall of middle box body is provided with the opening that communicates with the lower box body, and the opening is installed with the hollow screen that hangs in the upper of electric heating plate. Through the sliding partition plate, the positioning space that holds moxa bag is formed between two adjacent partition plates or between the partition plate and the side wall of middle box body, and moxa bag is located on the hollow screen. The side wall of middle box body is provided with the window for sliding partition plate. Each moxa bag includes wrapping paper and the ration moxa that is wrapped by wrapping paper. The utility model provides treatment material standardization configuration, shortens treatment preparation time, reduces the workload of medical staff, improves preparation work quality.

The invention discloses a six-axis treatment bed, and belongs to the technical field of radiotherapy beds. Comprising a ground rail X-axis, one side end of the ground rail X-axis is located in a treatment preparation room, the other side end of the ground rail X-axis is located in a treatment room, a chassis Y-axis and a chassis X-axis are integrated on the X-axis output end of the ground rail X-axis, and a lifting Z-axis is assembled on the output ends of the chassis Y-axis and the chassis X-axis. Precise pose adjustment of the treatment bed in six degrees of freedom is achieved, a ground rail X-axis, a chassis Y-axis and a chassis X-axis form a parallel layout, motion errors are dispersed along a plurality of independent axes and are non-linearly accumulated, the repeated positioning precision of a tail end bed board is remarkably improved, meanwhile, the modular quick-release design allows key components such as a sliding rail and a motor to be independently replaced, and the cost is reduced. The problems that in the prior art, an integrated structure is inconvenient to maintain and long in downtime are solved.

The invention discloses application of zyxin protein in preparation of a product for treating renal interstitial fibrosis caused by hypertension, and belongs to the technical field of biological medicine. The core effect of the zyxin protein in hypertensive nephropathy treatment through targeted regulation of a CDK8 / YAP signal axis is found for the first time, the target limitation of existing anti-renal fibrosis drugs is broken through, and clinical transformation can be achieved through the following modes that 1, a gene treatment preparation is constructed based on a zyxin coding sequence; the method comprises the steps of (1) screening a small molecule compound library for regulating and controlling the activity of a zyxin-CDK8 / YAP axis, (3) developing an HN typing diagnosis system with the zyxin expression level as a biomarker, and (4) exploring and developing the industrialization prospect of a new drug or a combination therapy on the basis of deeply researching the dose-effect relation of the zyxin in the aspects of reversing renal interstitial fibrosis and improving renal functions.

1. The name of the present design product: digital therapy center graphical user interface for electronic device. 2. The use of the present design product: an electronic device. 3. The design points of the present design product: in the graphical user interface. 4. The picture or photo that best shows the design points: design 1 front view. 5. The design 1 and design 2 rear view, left view, right view, top view and bottom view of the present design product are conventional designs, and the design 1 and design 2 rear view, left view, right view, top view and bottom view are omitted. 6. Design 1 is designated as the basic design. 7. The use of the graphical user interface: the interface of the present design product is a desktop display and an application display interface. 8. The human-computer interaction mode of the graphical user interface: design 1 front view shows the digital therapy center graphical user interface. When the user clicks / touches the open button in the digital cover therapy area in the design 1 front view interface, the interface changes from design 1 front view to design 1 change state diagram 1, which shows the digital cover therapy preparation interface, and the good button is displayed in design 1 change state diagram 1. When the user clicks / touches the good button in design 1 change state diagram 1, the interface changes from design 1 change state diagram 1 to design 1 change state diagram 2, which shows the digital cover therapy area on the left side of the interface, and the open button in the upper right corner of the digital cover therapy area in the digital cover therapy area is lit. The other contents displayed in design 1 change state diagram 2 are the same as the corresponding contents displayed in the interface shown in design 1 front view. When the user clicks / touches any application icon in the digital cover therapy area in design 1 change state diagram 2, the interface changes from design 1 change state diagram 2 to design 1 change state diagram 3, which shows the training progress bar of training with digital cover therapy on the top, and the blank area of design 1 change state diagram 3 is the specific picture and text content of the corresponding application. When the user clicks / touches the training progress bar in the digital cover therapy area in design 1 change state diagram 3, the interface changes from design 1 change state diagram 3 to design 1 change state diagram 4, which shows the training progress details of training with digital cover therapy on the top, and the blank area of design 1 change state diagram 4 is the specific picture and text content of the corresponding application. Design 2 front view shows the digital therapy center graphical user interface. When the user clicks / touches the open button in the digital cover therapy area in the design 2 main view interface, the interface changes from the design 2 main view to the design 2 change state view 1. When the user clicks / touches the good button in the design 2 change state view 1, the interface changes from the design 2 change state view 1 to the design 2 change state view 2. When the user clicks / touches any application icon in the digital cover therapy area in the design 2 change state view 2, the interface changes from the design 2 change state view 2 to the design 2 change state view 3, the upper part of the design 2 change state view 3 shows the training progress bar of the training using the digital cover therapy, and the blank area of the design 2 change state view 3 is the specific picture and text content of the corresponding application. When the user clicks / touches the training progress bar in the digital cover therapy area in the design 2 change state view 3, the interface changes from the design 2 change state view 3 to the design 2 change state view 4, the upper part of the design 2 change state view 4 shows the detailed training content of the training using the digital cover therapy, and the blank area of the design 2 change state view 4 is the specific picture and text content of the corresponding application. The design 2 change state view 1-4 respectively corresponds to the design 1 change state view 1-4.

The present invention relates to a treatment preparation device and a treatment apparatus, which can be positioned on a position where deviation is less likely to occur at the time of irradiation when a subject to be irradiated is positioned in a preparation room. The treatment preparation device (100) is provided with a peripheral portion simulation mechanism (102) which simulates a peripheral portion (104) of a fixation object (101) after being arranged in an irradiation room (3) when fixing the relative position of the fixation object and the subject to be irradiated in a preparation room (10). Therefore, when positioning a patient (Q) in the preparation room, the positioning can be performed by taking into account the peripheral portion of the fixation object in the irradiation room by using the peripheral portion simulation mechanism (102). That is, in the preparation room, the patient is fixed on a position where deviation is less likely to occur in the irradiation room on the basis of taking into account the positional relationship between the patient and the peripheral portion. By the above, when positioning the patient in the preparation room, the patient can be positioned on a position where deviation is less likely to occur at the time of irradiation.

To provide a mechanism for enabling a doctor to efficiently perform medical examination by confirming the preparation circumstances in the medical examination of a patient to be examined after a patient under medical examination at present.SOLUTION: This system is provided with a CPU113 for acquiring the patient information of a second patient to be examined after a first patient who is currently examined, a CPU133 for judging the preparation conditions in the examination of the second patient by using a photographic image photographed by an imaging device 140 on the patient side disposed so as to photograph the second patient, and a display part 111 for displaying the preparation conditions in the examination of the second patient during the examination of the first patient on the basis of the patient information of the second patient.SELECTED DRAWING: Figure 1

The application discloses a six-axis treatment bed and belongs to the technical field of radiotherapy treatment beds. The six-axis treatment bed comprises a ground rail X-axis, one end of the ground rail X-axis is located in a treatment preparation room, the other end is located in a treatment room, and a chassis Y-axis and a chassis X-axis are integrated on the X-axis output end of the ground rail X-axis. A lifting Z-axis is assembled on the output end of the chassis Y-axis and the chassis X-axis. The six-axis treatment bed replaces the traditional series mechanical arm design through a multi-slide rail parallel base structure, realizes precise position adjustment of the treatment bed in six degrees of freedom, and forms a parallel layout with the ground rail X-axis, the chassis Y-axis and the chassis X-axis. Motion errors are dispersed along multiple independent axes instead of being linearly accumulated, the repeatability of the end bed plate is significantly improved, and meanwhile, the modular quick-release design allows key components such as slide rails and motors to be replaced independently, thereby solving the problems of inconvenient maintenance and long downtime of the integral structure in the prior art.

The present invention belongs to the technical field of traditional Chinese medicine, and discloses an external umbilical therapy preparation for treating male infertility and a preparation method thereof. The external umbilical therapy preparation comprises the following raw materials in parts by weight: 12-16 parts of fructus cnidii, 12-18 parts of semen cuscutae, 12-18 parts of fructus lycii, 15-18 parts of galla chinensis, 12-18 parts of fructus mori, 15-18 parts of semen brassicae, 15-18 parts of semen vaccariae, 2-6 parts of flos carthami, 3-6 parts of flos rosae rugosae, 9-15 parts of stigma nelumbinis, 2-5 parts of pilose antler, 2-6 parts of lignum aquilariae resinatum, 15-18 parts of flos caryophylli, and 15-30 parts of ginger powder. The application operation of the umbilical therapy preparation described in the present invention is relatively simple. It adopts the method of combining external moxibustion umbilical paste with application, so as to achieve the purpose of combining medical treatment with nourishment, tonifying the kidney, generating essence and assisting fertility, and has no side effects. It is a method of treating with the characteristics of external treatment of traditional Chinese medicine.